Apimeds Pharmaceuticals US, Inc. (APUS)
NYSEAMERICAN: APUS · Real-Time Price · USD
0.900
+0.042 (4.90%)
At close: Jun 26, 2026, 4:00 PM EDT
0.910
+0.010 (1.11%)
After-hours: Jun 26, 2026, 8:00 PM EDT
Company Description
Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure.
The company was incorporated in 2020 and is based in Matawan, New Jersey. Apimeds Pharmaceuticals US, Inc. operates as a subsidiary of Inscobee., Inc.
Apimeds Pharmaceuticals US, Inc.
| Country | United States |
| Founded | 2020 |
| IPO Date | May 9, 2025 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| CEO | Vinod Menon |
Contact Details
Address: 100 Matawan Rd, Suite 325 Matawan, New Jersey 07747 United States | |
| Phone | 848-201-5010 |
| Website | mindwavedao.com |
Stock Details
| Ticker Symbol | APUS |
| Exchange | NYSEAMERICAN |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $4.00 |
| CIK Code | 0001894525 |
| CUSIP Number | 03771D102 |
| ISIN Number | US03771D1028 |
| Employer ID | 85-1099700 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Vinod Menon | Founder, Chief Executive Officer and Director |
| Erik C. Emerson | President |
| Erick J. Frim | Chief Financial Officer |
| Dr. Christopher M. H. Kim M.D. | Chief Medical Officer |
| Captain Sandeep Singh Yadav | Chief Operating Officer |
| Amardeep Singh | Chief Technology Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 26, 2026 | 10-Q | Quarterly Report |
| May 15, 2026 | NT 10-Q | Notification of inability to timely file Form 10-Q or 10-QSB |
| May 7, 2026 | SCHEDULE 13D/A | Filing |
| May 5, 2026 | 8-K | Current Report |
| May 4, 2026 | 10-K | Annual Report |
| May 4, 2026 | 8-K | Current Report |
| Apr 22, 2026 | 8-K | Current Report |
| Apr 16, 2026 | 8-K | Current Report |
| Apr 9, 2026 | 425 | Filing |
| Apr 9, 2026 | 8-K/A | [Amend] Current report |